Results 51 to 60 of about 377,194 (138)

Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data

EBioMedicine, 2015
Complex regional pain syndrome (CRPS) is a chronic pain disorder that typically follows trauma or surgery. Suspected CRPS reported after vaccination with human papillomavirus (HPV) vaccines led to temporary suspension of proactive recommendation of HPV ...
Frank Huygen, Kristin Verschueren, Candida McCabe, Jens-Ulrich Stegmann, Julia Zima, Olivia Mahaux, Lionel Van Holle, Maria-Genalin Angelo   +7 more
doaj   +1 more source

Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions

MedComm, Volume 7, Issue 3, March 2026.
Immune exhaustion is a well‐established hallmark of both cancer and chronic infection. This review proposes a novel “infection–exhaustion–tumor axis” framework, wherein chronic pathogens (e.g., oncogenic viruses) evade immune surveillance by hijacking inflammatory signaling to drive immune cell exhaustion, thereby creating immunosuppressive niches ...
Yali Song, Yazhi Mo, Si Chen, Yuemei Chen, Chunying Zhang, Shanying Deng, Juan Liao, Yi He, Wei Wang, Weidong Zheng, Tingting Zeng   +10 more
wiley   +1 more source

Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances

International Journal of Nanomedicine, 2022
Jiahui Zhang,1,* Jingyi Fan,1,* Mariusz Skwarczynski,1 Rachel J Stephenson,1 Istvan Toth,1– 3 Waleed M Hussein1 1School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, Australia; 2School of Pharmacy, The ...
Zhang J, Fan J, Skwarczynski M, Stephenson RJ, Toth I, Hussein WM   +5 more
doaj  

High‐Risk HPV in Men: A Hidden Threat to Public Health?

Reviews in Medical Virology, Volume 36, Issue 2, March 2026.
ABSTRACT High‐risk human papillomavirus (HR‐HPV) infection is a leading cause of several cancers, including those of the genital and oropharyngeal regions. While public health efforts have largely focused on women due to its link to cervical cancer, HPV also poses significant risks to men, particularly in the oropharyngeal regions. HR‐HPV prevalence in
Keesha L. Coker, Ethan L. Morgan
wiley   +1 more source

Place de la vaccination Gardasil® -Cervarix® dans la prévention du cancer du col de l'utérus [PDF]

, 2009
Avec près de 500 000 nouveaux cas diagnostiqués chaque année dans le monde et 270 000 décès, le cancer du col de l'utérus est un véritable problème de santé publique. Il représente la deuxième cause de cancer chez la femme dans le monde.
PUISSET, Florent, BONHOMME, Florence
core  

Vaccine Name Framing, Relationship Status, and Fear: Examining Heterosexual Men's Intention to Vaccinate Against Human Papillomavirus Infection

World Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Against the backdrop of calling for nonfemale‐oriented promotion of vaccination against human papillomavirus (HPV), this study explored three potential names—“HPV Vaccine,” “Cervical Cancer Vaccine,” and “Genital Warts Vaccine”—to promote vaccination against HPV infection among heterosexual men.
Timothy K. F. Fung, Judy Yuen‐man Siu, Ho Man Leung   +2 more
wiley   +1 more source

Cervarix - Preventing cervical cancer and other diseases related to HPV [PDF]

, 2008
Human papillomavirus (HPV) is the pathological agent required for the development and progression of precancerous lesions in the cervical epithelium. Just two HPV types account for around 70% of all cases of cervical cancer.
Tallia, AF, Stevens, R, Rasmussen, J, Gaw, A, Barakat, K, Dalrymple, J, Elward, K, Halpin, D, Schachter, M, North, F, LeFevre, M, Tamargo, J, Spann, S, Waller, D, Morrell, J, Uden, D, Kassianos, G, Kirby, M, Waite, M, Ganiats, T, Yawn, R, Price, D, Brown, P, Chambers, S, Yawn, B   +24 more
core  

Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation [PDF]

, 2020
Purpose. To evaluate medium-term clinical outcomes with XEN® 45 or XEN® 63 Gel Stent (Allergan, Dublin, Ireland) for treatment of primary open angle glaucoma (POAG). Materials and Methods.
Nuria Garzón, Fernández García, Aitor, Francisco Poyales, Andrango, Henry, Garzón Jiménez, Nuria, Mercedes García-Alonso, Poyales, Francisco, Aitor Fernández-García, Henry D. Andrango, Zhou, Ying, García Alonso, Mercedes, Ying Zhou   +11 more
core   +1 more source

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine

Human Vaccines & Immunotherapeutics, 2017
Human papillomavirus is considered the causative factor for cervical cancer, which accounts for approximately 5% of the global cancer burden and more than 600,000 new cases annually that are attributable to HPV infection worldwide.
Zhigang Zhang, Jun Zhang, Ningshao Xia, Qinjian Zhao   +3 more
doaj   +1 more source

HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 377-385, February 2026.
HPV vaccination in women undergoing active surveillance for CIN2 does not offer a protective effect against progression to CIN3+. Women should be informed that vaccination is not a substitute for clinical follow‐up and should be encouraged to adhere to recommended surveillance and treatment protocols Abstract Introduction Human papillomavirus (HPV ...
Dina O. Eriksen, Louise Krog, Eva B. Ostenfeld, Pernille T. Jensen, Kathrine D. Lycke, Therese K. Grønborg, Nicolas Wentzensen, Megan A. Clarke, Anne Hammer   +8 more
wiley   +1 more source